4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-17-059076
Options or other derivatives
- President and CEO acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shukla Sanjay President and CEO | 2017-11-01 | Grant or award · Employee Stock Option (right to buy) | +450,000 | 450,000 | D | ||
Loading xslF345X03/doc4.xml…